Vascular smooth muscle

Vascular Medicine

Volumn , Issue , 2006, Pages 17-30

  Berk, Bradford C ^a,b,c  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882542696     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0284-4.50008-7     Document Type: Chapter

References (128)

1. Schwartz SM, Reidy MR, Clowes A Kinetics of atherosclerosis: A stem cell model. Ann NYAcad Sci 1985, 454:292.
2. Majesky MW, Giachelli CM, Reidy MA, et al. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res 1992, 71:759.
3. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221.
4. Hu Y, Davison F, Ludewig B, et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106:1834.
5. Sata M Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 2003, 13:249.
6. Simper D, Stalboerger PG, Panetta CJ, et al. Smooth muscle progenitor cells in human blood. Circulation 2002, 106:1199.
7. Han CI, Campbell GR, Campbell JH Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2001, 38:113.
8. Caplice NM, Bunch TJ, Stalboerger PG, et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc NatlAcad Sci U S A 2003, 100:4754.
9. Ku DN, Giddens DP Pulsatile flow in a model carotid bifurcation. Arteriosclerosis 1983, 3:31.
10. Davies PF Endothelial cells, hemodynamic forces, and the localization of atherosclerosis. Endothelial Cells 1988, 123. CRC Press, Boca Raton, Fla. U.S. Ryan (Ed.).
11. Davies PF How do vascular endothelial cells respond to flow?. NIPS 1989, 4:22.
12. Mitsumata M, Fishel RS, Nerem RN, et al. Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells. Am J Physiol 1993, 265:H3.
13. Saouaf R, Takasaki I, Eastman E, et al. Fibronectin biosynthesis in the rat aorta in vitro: Changes due to experimental hypertension. J Clin Invest 1991, 88:1182.
14. Takasaki I, Chobanian AV, Sarzani P, et al. Effects of hypertension on fibronectin expression in the rat aorta. J Biol Chem 1990, 265:21935.
15. Carmeliet P Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389.
16. Hungerford JE, Little CD Developmental biology of the vascular smooth muscle cell: Building a multilayered vessel wall. J Vasc Res 1999, 36:2.
17. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242.
18. Campbell-Chamley JH, Campbell GR What controls smooth muscle phenotype. Atherosclerosis 1981, 40:347.
19. Oettgen P Transcriptional regulation of vascular development. Circ Res 2001, 89:380.
20. Owens GK Molecular control of vascular smooth muscle cell differentiation. Acta Physiol Scand 1998, 164:623.
21. Carmeliet P, Moons L, Dewerchin M, et al. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. Ann NY Acad Sci 1997, 811:191.
22. DeRuiter MC, Poelmann RE, Van Munsteren JC, et al. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res 1997, 80:444.
23. Vrancken Peeters MP, Gittenberger-de Groot AC, Mentink MM, et al. Smooth muscle cells and fibroblasts of the coronary arteries derive from epithelial-mesenchymal transformation of the epicardium. Anat Embryol (Berl) 1999, 199:367.
24. Rosenquist TH, Beall AC Elastogenic cells in the developing cardiovascular system: Smooth muscle, nonmuscle, and cardiac neural crest. Ann NY Acad Sci 1990, 588:106.
25. BergwerffM, Verberne ME, DeRuiter MC, et al. Neural crest cell contribution to the developing circulatory system: Implications for vascular morphology?. Circ Res 1998, 82:221.
26. Dettman RW, Denetclaw W, Ordahl CP, et al. Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev Biol 1998, 193:169.
27. Hellstrom M, Kalen M, Lindahl P, et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047.
28. Dickson MC, Martin JS, Cousins FM, et al. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knockout mice. Development 1995, 121:1845.
29. Li DY, Brooke B, Davis EC, et al. Elastin is an essential determinant of arterial morphogenesis. Nature 1998, 393:276.
30. Yanagisawa H, Hammer RE, Richardson JA, et al. Role of endothelin-1/endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest 1998, 102:22.
31. Gale NW, Baluk P, Pan L, et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 2001, 230:151.
32. Wang HU, Chen ZF, Anderson DJ Molecular distinction and angio-genic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998, 93:741.
33. Firulli AB, Miano JM, Bi W, et al. Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells:Association with the activated phenotype. Circ Res 1996, 78:196.
34. Gorski DH, Walsh K Control of vascular cell differentiation by homeobox transcription factors. Trends Cardiovasc Med 2003, 13:213.
35. Chisaka O, Capecchi MR Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature 1991, 350:473.
36. Witzenbichler B, Kureishi Y, Luo Z, et al. Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J Clin Invest 1999, 104:1469.
37. Berk BC Vascular smooth muscle growth: Autocrine growth mechanisms. Physiol Rev 2001, 81:999.
38. Gittenberger-de Groot AC, DeRuiter MC, et al. Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler Thromb Vasc Biol 1999, 19:1589.
39. Lin Q, Lu J, Yanagisawa H, et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 1998, 125:4565.
40. Miano JM Serum response factor: Toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003, 35:577.
41. Wang Z, Wang DZ, Pipes GC, et al. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA 2003, 100:7129.
42. Li S, Wang DZ, Wang Z, et al. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc NatlAcad Sci U S A 2003, 100:9366.
43. Yamagishi H, Olson EN, Srivastava D The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. J Clin Invest 2000, 105:261.
44. Kato Y, Kravchenko VV, Tapping RI, et al. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. Embo J 1997, 16:7054.
45. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485.
46. Ausoni S, Sartore S Cell lineages and tissue boundaries in cardiac arterial and venous poles: Developmental patterns, animal models, and implications for congenital vascular diseases. Arterioscler ThrombVasc Biol 2001, 21:312.
47. Moessler H, Mericskay M, Li Z, et al. The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 1996, 122:2415.
48. Tsuda T, Wang H, Timpl R, et al. Fibulin-2 expression marks transformed mesenchymal cells in developing cardiac valves, aortic arch vessels, and coronary vessels. Dev Dyn 2001, 222:89.
49. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403.
50. Glaser R, Lu MM, Narula N, et al. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 2002, 106:17.
51. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002, 346:5.
52. Archer SL, Huang JM, Hampl V, et al. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A 1994, 91:7583.
53. Carrier GO, Fuchs LC, WinecoffAP, et al. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am J Physiol 1997, 273:H76.
54. Swayze RD, Braun AP A catalytically inactive mutant of type I cGMP-dependent protein kinase prevents enhancement of large conductance, calcium-sensitive K+ channels by sodium nitroprus-side and cGMP. J Biol Chem 2001, 276:19729.
55. Jaggar JH, Porter VA, Lederer WJ, et al. Calcium sparks in smooth muscle. Am J Physiol Cell Physiol 2000, 278:C235.
56. Matrougui K, Tanko LB, Loufrani L, et al. Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries. Arterioscler Thromb Vasc Biol 2001, 21:1288.
57. Yamakawa T, Tanaka S, Numaguchi K, et al. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension 2000, 35:313.
58. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 2000, 275:21722.
59. Sandu OA, Ito M, Begum N Selected contribution: Insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle. JAppl Physiol 2001, 91:1475.
60. Cohen RA, Weisbrod RM, Gericke M, et al. Mechanism of nitric oxide-induced vasodilatation: Refilling of intracellular stores by sarcoplasmic reticulum Ca2+ATPase and inhibition of store-operated Ca2+ influx. Circ Res 1999, 84:210.
61. Komalavilas P, Lincoln TM Phosphorylation of the inositol 1, 4, 5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem 1996, 271:21933.
62. Schlossmann J, Ammendola A, Ashman K, et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Iβ. Nature 2000, 404:197.
63. Andriantsitohaina R, Lagaud GJ, Andre A, et al. Effects of cGMP on calcium handling in ATP-stimulated rat resistance arteries. Am J Physiol 1995, 268:H1223.
64. Horowitz A, Menice CB, Laporte R, et al. Mechanisms of smooth muscle contraction. Physiol Rev 1996, 76:967.
65. Cornwell TL, Pryzwansky KB, Wyatt TA, et al. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol 1991, 40:923.
66. Raeymaekers L, Hofmann F, Casteels R Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem J 1988, 252:269.
67. Yoshida Y, Toyosato A, Islam MO, et al. Stimulation of plasma membrane Ca2+ -pump ATPase of vascular smooth muscle by cGMP-dependent protein kinase: Functional reconstitution with purified proteins. Mol Cell Biochem 1999, 190:157.
68. Tamaoki J, Tagaya E, Nishimura K, et al. Role of Na+ - K+ ATPase in cyclic GMP-mediated relaxation of canine pulmonary artery smooth muscle cells. Br J Pharmacol 1997, 122:112.
69. Lee MR, Li L, Kitazawa T Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 1997, 272:5063.
70. Carvajal JA, Germain AM, Huidobro-Toro JP, et al. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 2000, 184:409.
71. Surks HK, Mochizuki N, Kasai Y, et al. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase I alpha. Science 1999, 286:1583.
72. Geisterfer AAT, Peach MJ, Owens GK Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988, 62:749.
73. Berk BC, Vallega G, Muslin AJ, et al. Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na+/H+ exchange. J Clin Invest 1989, 83:822.
74. Stouffer GA, Owens GK Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res 1992, 70:820.
75. Owens GK Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987, 9:178.
76. Schiffrin EL, Park JB, Intengan HD, et al. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000, 101:1653.
77. Thomas WA, Lee KT, Kim DN Cell population kinetics in atheroge-nesis: Cell births and losses in intimal cell mass-derived lesions in the abdominal aorta of swine. Ann NY Acad Sci 1985, 454:305.
78. Bennett MR, Evan GI, Schwartz SM Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995, 95:2266.
79. Kockx MM, Knaapen MW The role of apoptosis in vascular disease. J Pathol 2000, 190:267.
80. Rossig L, Dimmeler S, Zeiher AM Apoptosis in the vascular wall and atherosclerosis. Basic Res Cardiol 2001, 96:11.
81. Cooper AL, Beasley D Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells. Am J Physiol 1999, 277:H1326.
82. Alexander RW Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspective. Hypertension 1995, 25:155.
83. Griendling KK, Ushio-Fukai M Redox control of vascular smooth muscle proliferation. J Lab Clin Med 1998, 132:9.
84. Rao GN, Berk BC Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992, 70:593.
85. Baas AS, Berk BC Differential activation of mitogen-activated protein kinases by H2O2 and O2 in vascular smooth muscle cells. Circ Res 1995, 77:29.
86. Herbert JM, Bono F, Savi P The mitogenic effect of H2O2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor. FEBS Lett 1996, 395:43.
87. Delafontaine P, Ku L Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells. Cardiovasc Res 1997, 33:216.
88. Ruef J, Hu ZY, Yin LY, et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries: A novel role for reactive oxygen species in atherosclerosis. Circ Res 1997, 81:24.
89. Kayanoki Y, Higashiyama S, Suzuki K, et al. The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells. Biochem Biophys Res Commun 1999, 259:50.
90. Liao D-F, Jin Z-G, Baas AS, et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 2000, 275:189.
91. Sundaresan M, Yu ZX, Ferrans VJ, et al. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270:296.
92. Griendling KK, Minieri CA, Ollerenshaw JD, et al. Angiotensin II stimulates NADH and NADPH oxidase activation in cultured vascular smooth muscle cells. Circ Res 1994, 74:1141.
93. Suh YA, Arnold RS, Lassegue B, et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999, 401:79.
94. Rao GN Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene 1996, 13:713.
95. Rao GN, Lassegue B, Griendling KK, et al. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: Role of protein kinase C. NuclAcids Res 1993, 21:1259.
96. Feng Y, Yang JH, Huang H, et al. Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells. Circ Res 1999, 85:1118.
97. Wilson E, Mai Q, Sudhir K, et al. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol 1993, 123:741.
98. Sudhir K, Wilson E, Chatterjee K, et al. Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. J Clin Invest 1993, 92:3003.
99. Standley PR, Obards TJ, Martina CL Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: Implications in vascular hyperplasia. Am J Physiol 1999, 276:E697.
100. Li Q, Muragaki Y, Hatamura I, et al. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-beta. J Vasc Res 1998, 35:93.
101. Fath KA, Alexander RW, Delafontaine P Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circ Res 1993, 72:271.
102. Negoro N, Kanayama Y, Haraguchi M, et al. Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo: An autocrine mechanism promoting hypertensive vascular hypertrophy. J Clin Invest 1995, 95:1140.
103. Birukov KG, Bardy N, Lehoux S, et al. Intraluminal pressure is essential for the maintenance of smooth muscle caldesmon and filamin content in aortic organ culture. Arterioscler Thromb Vasc Biol 1998, 18:922.
104. Ueba H, Kawakami M, Yaginuma T Shear stress as an inhibitor of vascular smooth muscle cell proliferation: Role of transforming growth factor-beta 1 and tissue-type plasminogen activator. ArteriosclerThromb Vasc Biol 1997, 17:1512.
105. Hu Y, Bock G, Wick G, et al. Activation of PDGF receptor alpha in vascular smooth muscle cells by mechanical stress. FASEB J 1998, 12:1135.
106. deBlois D, Lombardi DM, Su EJ, et al. Angiotensin II induction of osteopontin expression and DNA replication in rat arteries. Hypertension 1996, 28:1055.
107. Ashizawa N, Graf K, Do YS, et al. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction. J Clin Invest 1996, 98:2218.
108. Pickering JG, Ford CM, Tang B, et al. Coordinated effects of fibro-blast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metallopro-teinases by human vascular smooth muscle cells: Evidence for repressed collagen production and activated degradative capacity. Arterioscler Thromb Vasc Biol 1997, 17:475.
109. Koyama H, Raines EW, Bornfeldt KE, et al. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 1996, 87:1069.
110. Galis ZS, Khatri JJ Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002, 90:251.
111. Kol A, Bourcier T, Lichtman AH, et al. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999, 103:571.
112. Libby P Inflammation in atherosclerosis. Nature 2002, 420:868.
113. Mach F, Schonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U SA 1997, 94:1931.
114. Griendling KK, Sorescu D, Ushio-Fukai M NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 2000, 86:494.
115. Reidy MA, Fingerle J, Lindner V Factors controlling the development of arterial lesions after injury. Circulation 1992, 86:III43.
116. Powell JS, Clozel JP, Muller RK, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989, 245:186.
117. Olson NE, Chao S, Lindner V, et al. Intimal smooth muscle cell proliferation after balloon catheter injury: The role of basic fibro-blast growth factor. Am J Pathol 1992, 140:1017.
118. Weir L, Chen D, Pastore C, et al. Expression of gax, a growth arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury. J Biol Chem 1995, 270:5457.
119. Melaragno MG, Wuthrich DA, Poppa V, et al. Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ Res 1998, 83:697.
120. Mulvany MJ, Baumbach GL, Aalkjaer C, et al. Vascular remodeling. Hypertension 1996, 28:505.
121. Langille BL, O'Donnell F Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986, 231:405.
122. Kohler TR, Kirkman TR, Kraiss LW, et al. Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts. Circ Res 1991, 69:1557.
123. Cho A, Mitchell L, Koopmans D, et al. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res 1997, 81:328.
124. Schaper W, Ito WD Molecular mechanisms of coronary collateral vessel growth. Circ Res 1996, 79:911.
125. Mulvany MJ, Hansen PK, Aalkjaer C Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrower lumen, a thicker media, and a greater number of smooth muscle cell layers. Circ Res 1978, 43:854.
126. Mulvany MJ, Baadrup U, Gundersen HJG Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional dissector. Circ Res 1985, 57:794.
127. Heagerty AM, Aalkjaer C, Bund SJ, et al. Small artery structure in hypertension: Dual processes of remodeling and growth. Hypertension 1993, 21:391.
128. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316:1371.